Wall Street analysts predict that Agilent Technologies, Inc. (NYSE:A) will announce $0.63 earnings per share (EPS) for the current quarter, according to Zacks. Seven analysts have provided estimates for Agilent Technologies’ earnings, with estimates ranging from $0.61 to $0.66. Agilent Technologies reported earnings of $0.59 per share in the same quarter last year, which would indicate a positive year over year growth rate of 6.8%. The business is expected to issue its next quarterly earnings report after the market closes on Monday, November 20th.

On average, analysts expect that Agilent Technologies will report full year earnings of $2.32 per share for the current financial year, with EPS estimates ranging from $2.30 to $2.35. For the next financial year, analysts expect that the business will report earnings of $2.59 per share, with EPS estimates ranging from $2.51 to $2.68. Zacks’ earnings per share calculations are an average based on a survey of sell-side research analysts that follow Agilent Technologies.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Tuesday, August 15th. The medical research company reported $0.59 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.52 by $0.07. The business had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.09 billion. Agilent Technologies had a return on equity of 16.95% and a net margin of 14.36%. The business’s revenue was up 6.7% on a year-over-year basis. During the same period in the previous year, the firm posted $0.49 earnings per share.

Several brokerages recently commented on A. BidaskClub cut Agilent Technologies from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Barclays PLC reissued a “buy” rating and set a $67.00 target price on shares of Agilent Technologies in a report on Wednesday, July 19th. Jefferies Group LLC reissued a “buy” rating and set a $66.00 target price on shares of Agilent Technologies in a report on Wednesday, August 9th. Deutsche Bank AG set a $68.00 target price on Agilent Technologies and gave the stock a “buy” rating in a report on Wednesday, August 16th. Finally, Janney Montgomery Scott boosted their target price on Agilent Technologies from $65.00 to $70.00 and gave the stock a “buy” rating in a report on Wednesday, August 16th. Four analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $66.70.

In other Agilent Technologies news, CFO Didier Hirsch sold 15,555 shares of the business’s stock in a transaction on Friday, September 15th. The shares were sold at an average price of $66.00, for a total transaction of $1,026,630.00. Following the sale, the chief financial officer now directly owns 178,557 shares of the company’s stock, valued at approximately $11,784,762. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Boon Hwee Koh sold 4,500 shares of the business’s stock in a transaction on Wednesday, August 30th. The shares were sold at an average price of $63.63, for a total transaction of $286,335.00. The disclosure for this sale can be found here. Insiders sold 165,720 shares of company stock worth $10,488,739 in the last ninety days.

A number of large investors have recently made changes to their positions in A. Dupont Capital Management Corp purchased a new position in shares of Agilent Technologies during the 3rd quarter valued at $101,000. Balentine LLC grew its holdings in shares of Agilent Technologies by 2.9% during the 2nd quarter. Balentine LLC now owns 1,794 shares of the medical research company’s stock valued at $106,000 after acquiring an additional 50 shares in the last quarter. Sun Life Financial INC grew its holdings in shares of Agilent Technologies by 26,144.4% during the 2nd quarter. Sun Life Financial INC now owns 2,362 shares of the medical research company’s stock valued at $140,000 after acquiring an additional 2,353 shares in the last quarter. Acrospire Investment Management LLC grew its holdings in shares of Agilent Technologies by 92.3% during the 2nd quarter. Acrospire Investment Management LLC now owns 2,500 shares of the medical research company’s stock valued at $148,000 after acquiring an additional 1,200 shares in the last quarter. Finally, Parallel Advisors LLC grew its holdings in shares of Agilent Technologies by 5.3% during the 2nd quarter. Parallel Advisors LLC now owns 2,623 shares of the medical research company’s stock valued at $157,000 after acquiring an additional 131 shares in the last quarter.

Shares of Agilent Technologies (NYSE:A) traded up $0.32 during midday trading on Tuesday, hitting $67.13. The stock had a trading volume of 1,536,300 shares, compared to its average volume of 1,820,754. The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.76 and a current ratio of 3.22. The firm has a market capitalization of $21,600.00, a P/E ratio of 29.17, a PEG ratio of 2.62 and a beta of 1.28. Agilent Technologies has a fifty-two week low of $42.92 and a fifty-two week high of $68.67.

The business also recently declared a quarterly dividend, which was paid on Wednesday, October 25th. Shareholders of record on Tuesday, October 3rd were issued a $0.132 dividend. The ex-dividend date of this dividend was Monday, October 2nd. This represents a $0.53 annualized dividend and a dividend yield of 0.79%. Agilent Technologies’s dividend payout ratio is currently 27.32%.

ILLEGAL ACTIVITY WARNING: “Zacks: Brokerages Anticipate Agilent Technologies, Inc. (A) to Announce $0.63 Earnings Per Share” was originally published by American Banking News and is owned by of American Banking News. If you are viewing this story on another domain, it was stolen and reposted in violation of US & international copyright and trademark law. The legal version of this story can be read at https://www.americanbankingnews.com/2017/11/14/zacks-brokerages-anticipate-agilent-technologies-inc-a-to-announce-0-63-earnings-per-share.html.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Get a free copy of the Zacks research report on Agilent Technologies (A)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.